According to @StockMKTNewz, Hims & Hers Health ($HIMS) announced it will cease sales of its compounded weight-loss pill just days after its launch. This decision follows the announcement of a federal investigation into the company prompted by the product's release. Such regulatory scrutiny could impact investor confidence and trading activity for $HIMS in the short term.